Effects of fluvoxamine on morphine-induced inhibition of gastrointestinal transit, antinociception and hyperlocomotion in mice (Q31888198)

4 July 2017

Effects of fluvoxamine on morphine-induced inhibition of gastrointestinal transit, antinociception and hyperlocomotion in mice (English)

1 reference

4 July 2017

1 reference

Ise Y

1

1 reference

4 July 2017

Katayama S

2

1 reference

4 July 2017

Hirano M

3

1 reference

4 July 2017

Aoki T

4

1 reference

4 July 2017

Narita M

5

1 reference

4 July 2017

Suzuki T

6

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

4 July 2017

1 reference

4 July 2017

299

1 reference

4 July 2017

1-2

1 reference

4 July 2017

29-32

1 reference

Interactions between different antidepressants and morphine alter gastrointestinal transit in mice.

4 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

Mediation of serotonin-induced analgesia by the 5HT2 receptor in the pentobarbital anesthetized mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

Electrocardiographic findings during extended clinical trials of fluvoxamine in depression: one years experience

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

Diagnosis of major depression in cancer patients according to four sets of criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

Two types of receptors for 5-hydroxytryptamine on the cholinergic nerves of the guinea-pig myenteric plexus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

Mental disorders in cancer patients: a study of 100 psychiatric referrals

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

The outcome of antidepressant use in the medically ill

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

The antinociceptive effect of fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

Fluoxetine attenuates morphine-induced locomotion and blocks morphine-sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

Effects of agents increasing serotonin transmission on the increase of dopamine metabolism caused by morphine in the rat nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

The D3-receptor agonist (+/-)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901768-7

7 January 2021

10.1016/S0304-3940(00)01768-7

Identifiers

DOI

1 reference

4 July 2017

1 reference